NFKB1 and glioma: In the present study, we found that SE, which could be a potential botanical extract candidate identified through our initial screening, dose-dependently inhibited AGEs-BSA-induced NF-κB activation in C6 glioma cells (Figure 1A) and competed with AGEs-BSA binding for the extracellular domain of RAGE (Figure 1B).